John Lunec Selected Research

John Lunec Research Topics

Disease

24	Neoplasms (Cancer) 04/2024 - 07/2003
15	Neuroblastoma 01/2019 - 07/2003
3	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 06/2016
3	Osteosarcoma (Osteogenic Sarcoma) 02/2021 - 03/2012
3	Sarcoma (Soft Tissue Sarcoma) 05/2014 - 03/2005
2	Adenocarcinoma 01/2022 - 07/2021
2	Neoplasm Metastasis (Metastasis) 02/2021 - 08/2014
2	Melanoma (Melanoma, Malignant) 12/2018 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 11/2016 - 06/2007
1	Leukemia 04/2024
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2023
1	Disease Resistance 07/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022
1	Hepatitis 10/2021
1	Carcinoma (Carcinomatosis) 02/2021
1	Hypoxia (Hypoxemia) 02/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2020
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2015
1	Metabolic Diseases (Metabolic Disease) 12/2012
1	Mesothelioma 06/2009
1	Malignant Mesothelioma 06/2009

Drug/Important Bio-Agent (IBA)

11	RG7388IBA 04/2024 - 04/2015
7	nutlin 3IBA 02/2024 - 06/2007
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2019
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
3	Dihydroorotate DehydrogenaseIBA 08/2023 - 01/2018
3	GSK2830371IBA 01/2022 - 01/2018
3	RNA (Ribonucleic Acid)IBA 10/2021 - 09/2007
3	siremadlinIBA 07/2021 - 01/2018
3	Tumor Suppressor Protein p14ARF (p14ARF)IBA 04/2015 - 02/2006
3	Messenger RNA (mRNA)IBA 01/2013 - 07/2003
2	rucaparibIBA 02/2024 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 07/2003
2	Matrix Metalloproteinases (MMPs)IBA 02/2021 - 07/2003
2	NucleotidesIBA 01/2020 - 04/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 04/2015
2	Androgen Receptors (Androgen Receptor)IBA 11/2016 - 06/2007
2	Cisplatin (Platino)FDA LinkGeneric 06/2016 - 04/2015
2	Pemetrexed (MTA)FDA Link 09/2015 - 12/2009
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2013 - 11/2007
2	N-acetyltalosaminuronic acid (NAT)IBA 12/2012 - 08/2003
2	Transcription Factors (Transcription Factor)IBA 07/2010 - 07/2003
2	LuciferasesIBA 03/2008 - 07/2003
2	3- (4- chlorophenyl)- 3- (4- hydroxy- 3,5- dimethoxybenzyloxy)- 2- propyl- 2,3- dihydroisoindol- 1- oneIBA 10/2006 - 03/2005
1	navitoclaxIBA 04/2024
1	adavosertibIBA 09/2023
1	Phosphotransferases (Kinase)IBA 09/2023
1	Retroelements (Retrotransposon)IBA 01/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2021
1	Oxygen (Dioxygen)IBA 02/2021
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 02/2021
1	LigandsIBA 01/2021
1	AntioxidantsIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Gemcitabine FDA Link 10/2020
1	ProdrugsIBA 01/2019
1	RO6839921IBA 01/2019
1	trametinibIBA 12/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2018
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 01/2018
1	Keratins (Keratin)IBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	VimentinIBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2016
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 05/2016
1	Adenosine Diphosphate (ADP)IBA 05/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2016
1	Lapatinib (GW572016)FDA Link 09/2015
1	Thymidylate SynthaseIBA 09/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2015
1	Topotecan (Hycamtin)FDA LinkGeneric 04/2015
1	Busulfan (Busulfex)FDA Link 04/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2014
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2014
1	Celecoxib (Celebrex)FDA Link 08/2014
1	RG7112IBA 05/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2012
1	Glucose (Dextrose)FDA LinkGeneric 12/2012
1	Glutamine (L-Glutamine)FDA Link 12/2012
1	Folic Acid AntagonistsIBA 12/2009
1	Indicators and Reagents (Reagents)IBA 12/2009
1	vatalanib (PTK787)IBA 06/2009
1	Tyrosine Kinase InhibitorsIBA 06/2009
1	Sunitinib (Sutent)FDA Link 06/2009
1	Gefitinib (Iressa)FDA Link 06/2009
1	vandetanib (ZD6474)IBA 06/2009

Therapy/Procedure

18	Therapeutics 04/2024 - 07/2003
9	Drug Therapy (Chemotherapy) 10/2020 - 07/2003
2	Drug Tapering 02/2024 - 01/2017
2	Ligation 02/2021 - 02/2011
1	Oral Administration 01/2021
1	Molecular Targeted Therapy 01/2019
1	Immunotherapy 03/2018